Skip to main content

Table 5 Serum fatty acid profile of dogs fed diets supplemented with silybin and commercial hepatoprotectant (EXP1)

From: Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs

FA (g/100 g FA) CON
(n = 18)
mean
HEP
(n = 18)
mean
SIL
(n = 18)
mean
SEM P
C14:0 0.25 0.20 0.24 0.01 NSD
C15:0 0.08b 0.13a 0.10ab 0.01 0.02
C16:0 11.4 11.5 1.8 0.24 NSD
C17:0 0.30b 0.39a 0.34ab 0.01 0.04
C18:0 17.2 17.7 18.4 0.25 NSD
C20:0 0.18 0.22 0.19 0.01 NSD
C22:0 1.27a 0.84b 1.11a 0.06 <  0.001
C23:0 0.01 0.01 0.01 0.001 NSD
C24:0 0.03 0.03 0.03 0.001 NSD
C14:1 0.04 0.04 0.03 0.001 NSD
C15:1 0.12 0.12 0.11 0.01 NSD
C16:1 1.15 1.33 1.19 0.08 NSD
C17:1 0.16 0.14 0.14 0.01 NSD
C18:1 t 9 0.11 0.10 0.12 0.01 NSD
C18:1 t 11 0.28 0.29 0.32 0.01 NSD
C18:1 cis 9 11.4 11.2 11.4 0.42 NSD
C20:1 trans 0.06 0.06 0.07 0.01 NSD
C22:1 n9 0.33 0.24 0.30 0.02 NSD
C18:2 c 9 c 12 25.7 27.4 27.2 0.47 NSD
C18:3 c 9 c 12 c 15 0.64 0.79 0.83 0.04 NSD
C18:3 n6 0.04 0.04 0.05 0.001 NSD
C20:2 0.16 0.14 0.16 0.01 NSD
C20:3 n6 19.0 17.7 16.8 0.50 NSD
C20:4 n6 0.02 0.02 0.02 0.001 NSD
C20:5 n3 0.99a 0.58b 0.54b 0.06 <  0.001
C22:5 n3 2.01 2.72 2.30 0.13 NSD
C22:6 n3 0.04 0.04 0.04 0.01 NSD
Others 9.79 8.09 9.30
SUM 100 100 100
1SFA 31.6 31.5 (1.30) 32.6 (2.10) 0.43 NSD
2UFA 68.4 68.5 (1.30) 67.4 (2.10) 0.43 NSD
3MUFA 19.7 18.9 (.96) 19.2 (1.15) 0.45 NSD
4PUFA 48.5 49.4 48.0 0.71 NSD
n-6 45.0 45.3 44.4 0.63 NSD
n-3 3.68 4.12 3.71 0.13 NSD
n6/n3 12.4 11.0 12.3 0.37 NSD
n6 PUFA 44.7 45.2 44.1 0.63 NSD
n3 PUFA 3.68 4.12 3.71 0.13 NSD
PUFA/SFA 1.55 1.57 1.48 0.04 NSD
LNA/LA 41.8 34.9 34.6 1.92 NSD
5MCFA 13.2 13.4 12.7 0.30 NSD
6LCFA 86.6 86.4 87.1 0.31 NSD
  1. Abbreviations: CON, control group; HEP, group fed diet supplemented with commercial hepatoprotectant containing silybin; SIL, group fed diet supplemented with pure silybin; SFA, saturated fatty acids; UFA, unsaturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; MCFA, medium chain fatty acids; LCFA, long chain fatty acids; NSD, not statistically different
  2. Superscripts a,b in the same row indicate significant differences between control versus treatment groups (P <  0.05)